Market Size in 2021 | Market Forecast in 2026 | CAGR (in %) | Base Year |
---|---|---|---|
USD 44.5 Billion | USD 103.4 Billion | 15.1% | 2021 |
FrequentlyAsked Questions
The increase in smoking cessation programs by businesses, the government, and non-governmental organizations (NGOs) to raise awareness of the harmful effects of smoking is anticipated to result in significant growth for the global market for nicotine replacement therapy in the upcoming years.
According to the report, the global nicotine replacement therapy market size was worth USD 44.5 billion in 2021 and is estimated to grow to USD 103.4 billion by 2028, with a compound annual growth rate (CAGR) of approximately 15.1% over the forecast period.
The North American region is leading the global nicotine replacement therapy market owing to the rising awareness against smoking as well as product development that serves in multiple ways according to user's preferences.
Some of the main competitors dominating the global nicotine replacement therapy market are Cipla Inc., Pfizer Inc., Johnson & Johnson Services, Inc., British American Tobacco p.l.c., Philip Morris Products S.A. (Altria Group), Imperial Brands, Glenmark, and Japan Tobacco Inc.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed